SRC and renal cell carcinoma: MIC-1, a bioactive compound in MO Lam., selectively inhibited renal cell carcinoma (RCC) growth by targeting PTP1B-mediated Src/Ras/Raf/ERK signaling without affecting non-RCC cancer cell lines [284].